ANI Pharmaceuticals, Inc. (ANIP) Hits Milestone with Cortrophin Gel Prefilled Syringe Launch
ANI Pharmaceuticals, Inc.
Insider Monkey Blog
Amphastar Pharmaceuticals, Inc. (AMPH) Secures FDA Approval for Generic Iron Sucrose Injection
Amphastar Pharmaceuticals, Inc.
Avadel Pharmaceuticals plc (AVDL)’s LUMRYZ™ Sales Surge 64% in Breakout Quarter
Avadel Pharmaceuticals plc (NASDAQ:AVDL), a Dublin-based biopharmaceutical company, is gaining attention in the sleep medicine space with its flagship product LUMRYZ™, the first...
FDA Accepts Lantheus Holdings, Inc. (LNTH)’ NDA for New PSMA Imaging Agent
Lantheus Holdings, Inc. (NASDAQ:LNTH), a leader in radiopharmaceuticals, is strengthening its position in diagnostic and therapeutic imaging with several recent milestones.
Dynavax Technologies Corporation (DVAX) Reports Record $92M HEPLISAV-B Revenue, Raises 2025 Outlook
Dynavax Technologies Corporation (NASDAQ:DVAX), a commercial-stage biopharmaceutical company specializing in innovative vaccines, is gaining momentum with strong financial results...
Novo Nordisk A/S (NVO) Wins U.S. Wegovy Approval for MASH, Expands to China Market
Novo Nordisk A/S (NYSE:NVO), a global pharmaceutical leader in diabetes and obesity care, continues to strengthen its position with new clinical data, expanded market approvals...
BioCryst Pharmaceuticals, Inc. (BCRX) Q2 Revenue Soars 49%, Hits Record $163.4 Million on ORLADEYO Surge
BioCryst Pharmaceuticals, Inc.
Neurocrine Biosciences, Inc. (NBIX) Beats Estimates on Neurology Drug Demand, Expands Payer Access
Neurocrine Biosciences, Inc.
Eli Lilly and Company (LLY)’s Oral Obesity Drug Orforglipron Achieves Breakthrough Phase 3 Results
Eli Lilly and Company (NYSE:LLY) tops our list for being one of the best pharmaceutical stocks.
11 Fastest Growing Small Cap Stocks to Buy
These days, everyone is obsessed with speed: fast fashion, fast food, fast internet.
NRx Pharmaceuticals, Inc. (NRXP)’ NRX-100 Wins Expanded FDA Fast Track for Suicidal Depression
NRx Pharmaceuticals, Inc.
Psyence Biomedical Ltd. (PBM) Achieves Breakthrough in High-Purity Ibogaine Production
Psyence Biomedical Ltd.
Relmada Therapeutics, Inc. (RLMD) Reports 91% Response Rate in Phase 2 Bladder Cancer Study
Relmada Therapeutics, Inc. (NASDAQ:RLMD) is a clinical-stage biotechnology company developing therapies for central nervous system disorders and oncology.
GH Research PLC (GHRS) Reports 73% Remission in Phase 2b Depression Trial
GH Research PLC (NASDAQ:GHRS) is a clinical-stage biopharmaceutical company developing innovative therapies for treatment-resistant depression (TRD) and other psychiatric and ...
Vistagen Therapeutics, Inc. (VTGN) Eyes Breakthrough with Phase 3 Social Anxiety Trial
Vistagen Therapeutics, Inc.
Bright Minds Biosciences Inc. (DRUG) Advances Phase 2 Trial for Drug-Resistant Epilepsy
Bright Minds Biosciences Inc.
Mind Medicine (MindMed) Inc. (MNMD)’s MM120 Earns FDA Breakthrough Status in Anxiety Treatment
Mind Medicine (MindMed) Inc.
COMPASS Pathways Plc (CMPS)’ Psilocybin Therapy Hits Phase 3 Success in Depression
COMPASS Pathways Plc (NASDAQ:CMPS), a biotechnology company specializing in innovative mental health treatments, is developing COMP360, a psilocybin-based therapy in late-stage...
Sage Therapeutics, Inc. (SAGE) Bought by Supernus to Boost Neuropsychiatric Portfolio
Sage Therapeutics, Inc.
Alkermes plc (ALKS) Completes Enrollment in Key Narcolepsy Trial, Data Due Q3 2025
Alkermes plc (NASDAQ:ALKS) tops our list for being one of the best psychedelic stocks. It is an Ireland-based biopharmaceutical company with U.S.
11 Best Performing Defense Stocks to Buy Now
The S&P Composite 1500 Aerospace & Defense Index gained 1.41% last week, as defense stocks surged following Commerce Secretary Howard Lutnick’s suggestion that the United States...
Bristol-Myers Squibb Company (BMY) Launches $300M Immunology Spinout with Bain Capital
Bristol-Myers Squibb Company (NYSE:BMY), a global biopharma leader, is making bold moves to strengthen its immunology presence through strategic partnerships and a growing pipeline...
Pfizer Inc. (PFE)’s Updated COVID-19 Vaccine COMIRNATY LP.8.1 Gets FDA Approval, Ships Nationwide
Pfizer Inc. (NYSE:PFE), a global pharmaceutical leader, continues to drive growth through innovation, commercial execution, and operational efficiency.
AbbVie Inc. (ABBV) Acquires Psychedelic Drug Developer Gilgamesh for $1.2B, Enters Mental Health Market
AbbVie Inc. (NYSE:ABBV), a global biopharmaceutical leader, continues to expand its presence in immunology, oncology, and neuroscience.
Johnson & Johnson (JNJ)’s Carvykti Sales Skyrocket 100% Amid Specialty Medicine Growth
Johnson & Johnson (NYSE:JNJ), a global leader in pharmaceuticals, medical devices, and consumer health, continues to drive growth in 2025 through strategic investments in innovation...
Eli Lilly and Company (LLY) Halts UK Mounjaro Shipments Ahead of Planned Price Increase
Eli Lilly and Company (NYSE:LLY) tops our list for being one of the high growth stocks.
Microsoft (MSFT) Expands AI Capabilities With MAI-Voice-1 and MAI-1-Preview Testing
Microsoft Corporation (NASDAQ:MSFT) ranks among the best predictive analytics stocks to buy right now.
Broadcom (AVGO) Enhances VMware Cloud Foundation With AI Services and Data Intelligence Launch
Broadcom Inc. (NASDAQ:AVGO) ranks among the best predictive analytics stocks to buy right now. Broadcom Inc.
Cloudflare (NET) Integrates With ChatGPT, Claude, Gemini to Boost Generative AI Security
Cloudflare, Inc. (NYSE:NET) ranks among the best predictive analytics stocks to buy right now. Cloudflare, Inc.
TD Cowen Confident in Workday’s (WDAY) Fiscal 2026 Revenue Outlook
Workday, Inc. (NASDAQ:WDAY) ranks among the best software stocks to buy right now.
Analysts Bullish on Palo Alto (PANW) as ARR Target of $15B by 2030 Remains on Track
Palo Alto Networks, Inc. (NASDAQ:PANW) ranks among the best software stocks to buy right now. In light of Palo Alto Networks, Inc.
UBS Maintains Autodesk (ADSK) Buy Rating Amid Strong Q2 Revenue and Billings Growth
Autodesk, Inc. (NASDAQ:ADSK) ranks among the best software stocks to buy right now.
KBW Highlights Upside Potential for Block (XYZ) Across Its Business Segments
Block Inc. (NYSE:XYZ) ranks among the best software stocks to buy right now.
UBS Maintains Fiscal 2025 Projections for Adobe (ADBE) Despite Target Cut
Adobe Inc. (NASDAQ:ADBE) ranks among the best software stocks to buy right now. On August 29, UBS reduced its price target for Adobe Inc.
KeyBanc Maintain Positive Bias on Intuit (INTU) Despite Tighter Pricing Comparisons
Intuit Inc. (NASDAQ:INTU) ranks among the best software stocks to buy right now. On August 22, KeyBanc maintained its Overweight rating on Intuit Inc.
Analysts Point to Federal Contracts as Key Driver for ServiceNow (NOW) Growth
ServiceNow, Inc. (NYSE:NOW) ranks among the best software stocks to buy right now. On August 25, Stifel reaffirmed its $1,200 price target and Buy rating for ServiceNow, Inc.
UBS Maintains Buy on Microsoft (MSFT) Amid AI Dominance
Microsoft Corporation (NASDAQ:MSFT) ranks among the best software stocks to buy right now.
RBC Capital Lifts Elastic (ESTC) Price Target GenAI and Strong Outlook
Elastic N.V. (NYSE:ESTC) ranks among the best predictive analytics stocks to buy right now. RBC Capital reaffirmed its Outperform rating on Elastic N.V.
Ionis Pharmaceuticals (IONS) Gains FDA Approval for HAE Drug, Piper Sandler Lifts Target
Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) ranks among the best mid-cap stocks with huge upside potential.
Jazz Pharmaceuticals (JAZZ) Price Target Raised After Modeyso Commercial Strategy Update
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) ranks among the best mid-cap stocks with huge upside potential.
Piper Sandler Initiates Nuvalent (NUVL) Amid Key Cancer Drug Catalysts
Nuvalent, Inc. (NASDAQ:NUVL) ranks among the best mid-cap stocks with huge upside potential. On August 19, Piper Sandler began coverage of Nuvalent, Inc.
Hedge Fund Resource Center
